أسيل سيوف في 18:18، 4 أبريل 2018

2018-04-04T18:18:18Z

أسيل سيوف في 18:05، 7 أغسطس 2013

2013-08-07T18:05:57Z

→ مراجعة أقدم		مراجعة 18:05، 7 أغسطس 2013
سطر 330:		سطر 330:
	* "RIEAs", "RARIs", ""TCAs", "MAOIs" or "AZPs"\|example=AZPs}}		* "RIEAs", "RARIs", ""TCAs", "MAOIs" or "AZPs"\|example=AZPs}}
	[[Category:Antidepressants]]		[[Category:Antidepressants]]
	[[Category:Drug_templates by ATC]]		<noinclude>[[Category:Drug_templates by ATC]]</noinclude>

	</noinclude>		</noinclude>

إدارة الموسوعة 1: مراجعة واحدة

2013-08-07T15:34:31Z

مراجعة واحدة

صفحة جديدة

{{Navbox with collapsible groups
| name = Antidepressants
| title = [[Antidepressant]]s ([[ATC code N06#N06A|N06A]])
|listclass = hlist
| state = {{{state<includeonly>|collapsed</includeonly>}}}
| selected = {{{1|}}}

| group1 = Specific [[reuptake]] [[Reuptake inhibitor|inhibitor]]s (RIs), [[Reuptake enhancer|enhancer]]s (REs), and [[releasing agent]]s (RAs)
| abbr1 = RIEAs
| list1 = {{Navbox subgroup

| group1 = [[Selective serotonin reuptake inhibitor]]s (SSRIs)
| list1 =
* [[Alaproclate]]
* [[Citalopram]]
* [[Escitalopram]]
* [[Femoxetine]]
* [[Fluoxetine]]#
* [[Fluvoxamine]]
* [[Indalpine]]
* [[Ifoxetine]]
* [[Litoxetine]]
* [[Omiloxetine]]
* [[Panuramine]]
* [[Paroxetine]]
* [[Pirandamine]]
* [[Seproxetine]]
* [[Sertraline]]#
* [[Zimelidine]]‡

| group2 = [[Serotonin–norepinephrine reuptake inhibitor]]s (SNRIs)
| list2 =
* [[Clovoxamine]]
* [[Desvenlafaxine]]
* [[Duloxetine]]
* [[Levomilnacipran]]
* [[Eclanamine]]
* [[Milnacipran]]
* [[Sibutramine]]
* [[Venlafaxine]]

| group3 = [[Serotonin–norepinephrine–dopamine reuptake inhibitor]]s (SNDRIs)
| list3 =
* [[Amitifadine]]
* [[Bicifadine]]
* [[Brasofensine]]
* [[BTS 74,398|BTS-74,398]]
* [[Cocaine]]
* [[Diclofensine]]
* [[DOV-102,677]]
* [[DOV-216,303]]
* [[EXP-561]]
* [[Fezolamine]]
* [[JNJ-7925476]]
* [[NS-2359]]
* [[PRC200-SS]]
* [[Pridefine]]
* [[SEP-225289|SEP-225,289]]
* [[SEP-227,162]]
* [[Tesofensine]]

| group4 = [[Norepinephrine reuptake inhibitor]]s (NRIs)
| list4 =
* [[Amedalin]]
* [[Atomoxetine|Atomoxetine/Tomoxetine]]
* [[Binedaline]]
* [[Ciclazindol]]
* [[Daledalin]]
* [[Edivoxetine]]
* [[Esreboxetine]]
* [[Lortalamine]]
* [[Mazindol]]
* [[Nisoxetine]]
* [[Reboxetine]]
* [[Talopram]]
* [[Talsupram]]
* [[Tandamine]]
* [[Viloxazine]]

| group5 = [[Dopamine reuptake inhibitor]]s (DRIs)
| list5 =
* [[Medifoxamine]]
* [[Vanoxerine]]

| group6 = [[Norepinephrine-dopamine reuptake inhibitor]]s (NDRIs)
| list6 =
* [[Amineptine]]
* [[Bupropion|Bupropion/Amfebutamone]]#
* [[Cilobamine]]
* [[Manifaxine]]
* [[Methylphenidate]]
* [[Nomifensine]]
* [[Radafaxine]]
* [[Tametraline]]

| group7 = [[Norepinephrine-dopamine releasing agent]]s (NDRAs)
| list7 =
* [[Amphetamine]]
* [[Befuraline]]
* [[Lisdexamfetamine]]
* [[Methamphetamine]]
* [[Phenethylamine]]
* [[Piberaline]]
* [[Tranylcypromine]]

| group8 = [[Serotonin-norepinephrine-dopamine releasing agent]]s (SNDRAs)
| list8 =
* [[4-Me-αMT|4-Methyl-αMT]]
* [[alpha-Ethyltryptamine|αET/Etryptamine]]
* [[alpha-Methyltryptamine|αMT/Metryptamine]]

| group9 = [[Selective serotonin reuptake enhancer]]s (SSREs)
| list9 =
* [[Tianeptine]]

| group10 = Others
| list10 =
* [[Indeloxazine]]
* [[Teniloxazine]]
* [[Tramadol]]
* [[Viqualine]]

}}

| group2 = [[Receptor antagonist]]s and/or [[reuptake inhibitor]]s
| abbr2 = RARIs
| list2 = {{Navbox subgroup

| group1 = [[Serotonin antagonist and reuptake inhibitor|Serotonin antagonists and reuptake inhibitor]]s (SARIs)
| list1 =
* [[Etoperidone]]
* [[Lubazodone]]
* [[Nefazodone]]
* [[Mepiprazole]]
* [[Trazodone]]

| group2 = [[Noradrenergic and specific serotonergic antidepressant]]s (NaSSAs)
| list2 =
* [[Aptazapine]]
* [[Esmirtazapine]]
* [[Mianserin]]
* [[Mirtazapine]]
* [[Setiptiline|Setiptiline/Teciptiline]]

| group3 = [[Norepinephrine-dopamine disinhibitor]]s (NDDIs)
| list3 =
* [[Agomelatine]]

| group4 = Serotonin modulators and stimulators (SMSs)
| list4 =
* [[Vortioxetine]]

| group5 = Others
| list5 =
* [[Tedatioxetine]]
* [[Vilazodone]]

}}

| group3 = [[Heterocyclic antidepressant]]s ([[bicyclic antidepressant|bi-]], [[tricyclic antidepressant|tri-]], and [[tetracyclic antidepressant|tetracyclic]]s)
| abbr3 = TCAs
| list3 = {{Navbox subgroup

| group1 = [[Bicyclic molecule|Bicyclic]]s
| list1 =
* [[Tiazesim]]
* [[Tofenacin]]

| group2 = [[Tricyclic]]s
| list2 =
* [[Amezepine]]
* [[Amineptine]]
* [[Amitriptyline]]#
* [[Amitriptylinoxide]]
* [[Azepindole]]
* [[Butriptyline]]
* [[Cianopramine]]
* [[Clomipramine]]
* [[Cotriptyline]]
* [[Cyanodothiepin]]
* [[Demexiptiline]]
* [[Depramine]]/[[Balipramine]]
* [[Desipramine]]
* [[Dibenzepin]]
* [[Dimetacrine]]
* [[Dosulepin|Dosulepin/Dothiepin]]
* [[Doxepin]]
* [[Enprazepine]]
* [[Fluotracen]]
* [[Hepzidine]]
* [[Homopipramol]]
* [[Imipramine]]
* [[Imipraminoxide]]
* [[Intriptyline]]
* [[Iprindole]]
* [[Ketipramine]]
* [[Litracen]]
* [[Lofepramine]]
* [[Losindole]]
* [[Mariptiline]]
* [[Melitracen]]
* [[Metapramine]]
* [[Mezepine]]
* [[Naranol]]
* [[Nitroxazepine]]
* [[Nortriptyline]]
* [[Noxiptiline]]
* [[Octriptyline]]
* [[Opipramol]]
* [[Pipofezine]]
* [[Propizepine]]
* [[Protriptyline]]
* [[Quinupramine]]
* [[Tampramine]]
* [[Tianeptine]]
* [[Tienopramine]]
* [[Trimipramine]]

| group3 = [[tetracyclic antidepressant|Tetracyclics]]
| list3 =
* [[Amoxapine]]
* [[Aptazapine]]
* [[Azipramine]]
* [[Ciclazindol]]
* [[Ciclopramine]]
* [[Esmirtazapine]]
* [[Maprotiline]]
* [[Mazindol]]
* [[Mianserin]]
* [[Mirtazapine]]
* [[Oxaprotiline]]
* [[Setiptiline|Setiptiline/Teciptiline]]
}}

| group4 = [[Monoamine oxidase inhibitor]]s (MAOIs)
| abbr4 = MAOIs
| list4 = {{Navbox subgroup

| group1 = Nonselective
| list1 =
* ''Irreversible:'' [[Benmoxin]]
* [[Carbenzide]]
* [[Cimemoxin]]
* [[Domoxin]]
* [[Echinopsidine]]
* [[Iproclozide]]
* [[Iproniazid]]
* [[Isocarboxazid]]
* [[Mebanazine]]
* [[Metfendrazine]]
* [[Nialamide]]
* [[Octamoxin]]
* [[Phenelzine]]
* [[Pheniprazine]]
* [[Phenoxypropazine]]
* [[Pivalylbenzhydrazine]]
* [[Safrazine]]
* [[Tranylcypromine]]

* ''Reversible:'' [[Caroxazone]]
* [[Paraxazone]]
* [[Quercetin]]

| group2 = MAOA-Selective
| list2 =
* ''Irreversible:'' [[Clorgiline]]

* ''Reversible:'' [[Amiflamine]]
* [[Bazinaprine]]
* [[Befloxatone]]
* [[Berberine]]
* [[Brofaromine]]
* [[Cimoxatone]]
* [[Esuprone]]
* [[Eprobemide]]
* [[Harmala alkaloid|Harmala Alkaloid]]s ([[Harmine]]
* [[Harmaline]]
* [[Tetrahydroharmine]]
* [[Harmala alkaloid#Chemical forms|Harman]]
* [[Norharman]], etc)
* [[Methylene blue|Methylene Blue]]
* [[Metralindole]]
* [[Minaprine]]
* [[Moclobemide]]
* [[Pirlindole]]
* [[Sercloremine]]
* [[Tetrindole]]
* [[Toloxatone]]
* [[CX157|Tyrima]]

| group3 = MAOB-Selective
| list3 =
* ''Irreversible:'' [[Ladostigil]]
* [[Mofegiline]]
* [[Pargyline]]
* [[Rasagiline]]
* [[Selegiline]]

* ''Reversible:'' [[Lazabemide]]
* [[Milacemide]]

}}

| group5 = [[Azapirone]]s and other [[5-HT1A receptor|5-HT1A receptor]] [[Serotonin receptor agonist|agonist]]s
| abbr5 = AZPs
| list5 =
* [[Alnespirone]]
* [[Aripiprazole]]
* [[Befiradol]]
* [[Buspirone]]
* [[Eptapirone]]
* [[Flesinoxan]]
* [[Flibanserin]]
* [[Gepirone]]
* [[Ipsapirone]]
* [[Oxaflozane]]
* [[Tandospirone]]
* [[Vilazodone]]
* [[Zalospirone]]

| list9 = {{PharmNavFootnote}}

| belowstyle = background: transparent; padding: 0px;
| below = {{Psychology navs}}

}}<noinclude>
{{collapsible option}}
 
{{Collapsible sections option | list =
* "RIEAs", "RARIs", ""TCAs", "MAOIs" or "AZPs"|example=AZPs}}
[[Category:Antidepressants]]
[[Category:Drug_templates by ATC]]

</noinclude>

قالب:Antidepressants - تاريخ المراجعة

أسيل سيوف في 18:18، 4 أبريل 2018

أسيل سيوف في 18:05، 7 أغسطس 2013

إدارة الموسوعة 1: مراجعة واحدة